Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Clinical Genitourinary Cancer|May 22, 2024
Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25)Elisabetta Gambale, Marco Maruzzo, Carlo Messina, et al.
Cancer Immunology, Immunotherapy : CII|February 14, 2026
Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25Giandomenico Roviello, Elisabetta Gambale, Irene De Gennaro Aquino, et al.
Frontiers in Immunology|June 29, 2026
Effectiveness and safety of avelumab maintenance in patients aged ≥75 years with advanced urothelial cancer: a sub-analysis of the meet-URO 25 (MALVA) studyGiandomenico Roviello, Elisabetta Gambale, Irene De Gennaro Aquino, et al.
Clinical Genitourinary Cancer|May 1, 2026
Concomitant medications and survival outcomes in patients receiving avelumab maintenance for advanced urothelial carcinoma: sub analysis of Meet-URO 25 studyGiandomenico Roviello, Martina Catalano, Elisabetta Gambale, et al.
Pageof 12